4512.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Stats
Dzisiejszy wolumen	27 000.00
Średni wolumen	152 208
Kapitalizacja rynkowa	7.95B
EPS	¥0 ( 2024-02-05 )
Następna data zysków	( ¥0 ) 2024-05-12
Last Dividend	¥3.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-44.64
ATR14	¥0.371 (0.16%)

Wolumen Korelacja

Długi: 0.14 (neutral)

Krótki: -0.39 (neutral)

Signal:(39.173) Neutral

Wakamoto Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Wakamoto Pharmaceutical Korelacja - Waluta/Towar

-0.11
( neutral )

0.00
( neutral )

0.28
( neutral )

0.11
( neutral )

Wakamoto Pharmaceutical Finanse

Annual	2022
Przychody:	¥8.66B
Zysk brutto:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Przychody:	¥8.66B
Zysk brutto:	¥4.11B (47.44 %)
EPS:	¥3.98

FY	2022
Przychody:	¥8.38B
Zysk brutto:	¥4.36B (51.96 %)
EPS:	¥6.87

FY	2021
Przychody:	¥8.89B
Zysk brutto:	¥4.49B (50.45 %)
EPS:	¥-17.34

Financial Reports:

No articles found.

Wakamoto Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥3.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Wakamoto Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.84 - average (61.59%) | Divividend Growth Potential Score: 3.11 - Decrease likely (37.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥2.50	2001-03-27
Last Dividend	¥3.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	17	--
Total Paid Out	¥45.50	--
Avg. Dividend % Per Year	0.00%	--
Score	1.71	--
Div. Sustainability Score	5.84
Div.Growth Potential Score	3.11
Div. Directional Score	4.47	--

Next Divdend (Est)
(2025-02-24)

¥0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.71

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8038.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7283.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6533.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
5805.T	Ex Dividend Junior	2023-09-28	Sporadic	0.00%
4548.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3771.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
3038.T	Ex Dividend Junior	2023-10-30	Annually	0.00%
1925.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9900.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
8935.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0223	1.500	-0.445	-0.668	[0 - 0.5]
returnOnAssetsTTM	-0.0116	1.200	-0.388	-0.466	[0 - 0.3]
returnOnEquityTTM	-0.0149	1.500	-1.277	-1.915	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.52	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.24	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.860	1.500	0.780	1.171	[0.2 - 2]
debtRatioTTM	0.00656	-1.500	9.89	-10.00	[0 - 0.6]
interestCoverageTTM	-264.52	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
freeCashFlowPerShareTTM	23.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00855	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.470	1.000	5.50	5.50	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0190	1.000	-2.38	-2.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	8.21	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.523	0.800	9.85	7.88	[0.5 - 2]
Total Score				5.84

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-44.73	1.000	-4.62	0	[1 - 100]
returnOnEquityTTM	-0.0149	2.50	-0.821	-1.915	[0.1 - 1.5]
freeCashFlowPerShareTTM	23.64	2.00	2.12	10.00	[0 - 30]
dividendYielPercentageTTM	1.310	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	23.64	2.00	2.12	4.24	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.063	1.500	6.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.93	0	[0.1 - 0.5]
Total Score				3.11

Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.